prednisone,cyclophosphamide,rituximab,vincristine,doxorubicin,polatuzumab vedotin
roche
['pola', 'leusm', 'dlbcl', 'lymphoma', 'lymsm', 'polarix']
#17icml reports on ad hoc analysis of the polarix trial, evaluating patients with dlbcl treated with first-line r-chop. results confirm pola-r-chp reduced risk of refractory disease compared with r-chop #lymsm #leusm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm